More Than 80 Companies Currently Claim To Offer Manufacturing Related Services


More than 80 companies currently claim to offer manufacturing related services

Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge.


To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this link


The USD 5.8 billion (by 2030) financial opportunity within the oligonucleotide synthesis, modification and purification services market has been analyzed across the following segments:

  • Type of manufacturing 
  • Custom manufacturing
  • Large-scale manufacturing


  • Type of Oligonucleotides manufactured
  • Antisense Oligonucleotides
  • miRNAs
  • shRNAs
  • siRNAs
  • Other Oligonucleotides


  • Scale of operation
  • Clinical
  • Commercial


  • Purpose of production
  • In-house
  • Outsourced


  • Target therapeutic area
  • Autoimmune Disorders
  • Cardiovascular Disorders
  • Genetic Disorders
  • Infectious Diseases
  • Metabolic Disorders
  • Neuromuscular Disorders
  • Oncological Disorders
  • Ophthalmic Disorders
  • Other Therapeutic Areas


  • Size of manufacturer
  • Small
  • Mid-sized
  • Large


  • Key Geographical Region 
  • North America
  • Europe
  • Asia-Pacific and Rest of the World 


The Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • Agilent Technologies
  • Ajinomoto Bio-Pharma Services
  • BioSpring
  • CordenPharma
  • Integrated DNA Technologies
  • Kaneka Eurogentec
  • LGC Biosearch Technologies
  • Microsynth
  • Nitto Denko Avecia
  • Sigma Aldrich
  • Thermo Fisher Scientific
  • Trilink Biotechnologies


Table of Contents


  1. 1. Preface

    Executive Summary

  2. Introduction

  3. Market Landscape: Oligonucleotide Manufacturers (Research and Diagnostic Applications)

  4. Market Landscape: Oligonucleotide Manufacturers (Therapeutic Applications)

  5. Company Competitiveness Analysis: Oligonucleotide Manufacturers (Research and Diagnostic Applications)

  6. Company Competitiveness Analysis: Oligonucleotide Manufacturers (Therapeutic Applications)

  7. Company Profiles: Oligonucleotide Manufacturers (Research and Diagnostic Applications)

  8. Company Profiles: Oligonucleotide Manufacturers (Therapeutic Applications)

  9. Partnerships and Collaborations

  10. Recent Expansions

  11. Clinical Trial Analysis


  1. Capacity Analysis


  1. Demand Analysis

  2. Market Sizing and Opportunity Analysis


  1. Swot Analysis

  2. Survey Analysis


  1. Executive Insights


  1. Concluding Remarks


  1. Appendix 1: Tabulated Data


  1. Appendix 2: List of Companies and Organizations


To purchase a copy, please visit


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415


Keywords: claims roots analysis


Other related blogs

The “Prefilled Syringe Fill / Finish Service Providers, 2020-2030” report features an extensive study of the current market

By : Roots Analysis

Key Inclusions A detailed review of the overall landscape of companies offering contract fill / f..

The prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%, till 2030

By : Roots Analysis

Roots Analysis has done a detailed study on Prefilled Syringe Fill / Finish Services Market, 2020-20..

The prefilled syringe fill / finish services market is estimated to is estimated to reach close to USD 3 Billion by 2030

By : Roots Analysis

The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, h..